Antibody Therapeutics Patients First!

공지사항

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to present at the company presentation session at BIO 2018.
  • 글쓴이 관리자
  • 작성일 2018-08-06 13:24:18
  • 조회수 48

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to present at the company presentation session at BIO 2018(http://convention.bio.org/2018/). 


Company Name: PharmAbcine

Presentation Date: Tuesday, June 5th

 

Presentation Time: 11:15:00 AM

 

Presentation Room: Theater 1

 

Speaker: Jin-San Yoo

 

 

For investors attending the BIO 2018, please contact PharmAbcine Investor Relations and business development to schedule a meeting with management at sungwoo.kim@pharmabcine.com.

 

목록





이전글 PharmAbcine Announces FDA Orphan Drug Designation Granted to TTAC-0001 for Gliob...
다음글 PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...